PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1976; 69(Suppl 1): 54–58.
PMCID: PMC1863608

Rehabilitation of the Chronic Schizophrenic Patient

Psychopharmacological Aspects

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (799K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Collard J. The main clinical classifications of neuroleptics. Acta Psychiatr Belg. 1974 Sep;74(5):447–461. [PubMed]
  • Fog R, Pakkenberg H. Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Acta Neurol Scand. 1970;46(2):249–251. [PubMed]
  • Gerlach J, Lühdorf K. The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. Psychopharmacologia. 1975 Oct 14;44(1):105–110. [PubMed]
  • Hogarty GE, Goldberg SC. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. Arch Gen Psychiatry. 1973 Jan;28(1):54–64. [PubMed]
  • LAUBER H. STUDIE ZUR FRAGE DER KRANKHEITSDAUER UNTER BEHANDLUNG MIT PSYCHOPHARMAKA. Nervenarzt. 1964 Nov;35:488–491. [PubMed]
  • Pakkenberg H, Fog R, Nilakantan B. The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations. Psychopharmacologia. 1973;29(4):329–336. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press